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Glycosphingolipids were shown to persist in human fecal excretions from birth up 2 years of age. The pat- 
tern of glycosphingolipids was dependent on blood group and secretor status of the child and changed dra- 
matically during the first months of life. Perinatally cerebroside, hematoside and blood group active fucoli- 
pids were dominating among fecal glycolipids. From the time of weaning lactosylceramide abruptly became 
and then persisted as a dominating glycolipid although cerebroside, complex gangliosides and blood group 
active fucolipids could still be detected in feces even at 2 years of age. 
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1. INTRODUCTION 
Blood group ABH-activity found in human 
meconium [l] was shown to rapidly diminish dur- 
ing the first few days of life [2]. The initial activity 
found in the water soluble mucin fraction was 
thought to be degraded by bacterial glycosidases as 
later illustrated on defined mucins in a series of 
papers by Hoskins et al. ([3,4] and references 
therein). More recently, however, blood group A- 
active oligosaccharides have been isolated in large 
quantities from feces of a breast-fed blood group 
A secretor infant [5]. 
Human meconium has been shown to be rich in 
blood group active glycosphingolipids reflecting 
the patterns of fetal intestinal cells [6]. After 
discovering glycosphingolipids . to be potential 
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receptors for bacteria [7], an ecological and protec- 
tive role for these substances in the meconium at 
the time of colonization was suggested ]I$]. Thus, 
by a specific binding of bacteria to luminal 
glycosphingolipids the uncontrolled infiltration 
and colonization of the intestinal epithelium could 
possibly be reduced and delayed until the protec- 
tive factors of human colostrum and milk, i.e. 
bifidus factors, sectory IgA, lymphocytes and 
phagocytic cells reached their destinations in the 
gut t91. 
Recently, we have found that glycosphingolipids 
excreted in the feces of conventional rats were 
enriched in lactosylceramide, depleted in 
hematoside (GM3) but contained all the blood 
group A-, B-, and H-activities of the intestinal cells 
of these rats and also of the feces of germ-free rats 
of the same strain [lo]. The accumulation of lac- 
tosylceramide was of particular interest since this 
specific glycolipid has been shown in vitro to bind 
several anaerobic bacteria of the indigenous in- 
testinal flora and also several pathogens [11,12]. 
The present paper is, to our knowledge, the first 
report of a persistent glycosphingolipid excretion 
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in feces of newborns and young children and serves 
to illustrate the relevance of studies on luminal 
glycosphingolipids. 
2. MATERIALS AND METHODS 
Feces was collected from one child, M.L., at 1, 
2, 3, 4 and 5 months of age and from another 
child, J.H., at 23 months of age. M.L. was com- 
pletely breast-fed during the first 2 months, then 
fed on a mixed diet with decreasing amounts of 
breast milk for 3 months and with less than 5% be- 
ing breast milk at 5 months of age. J.H. was taking 
only solid food. Feces samples were frozen 
(- 20°C) immediately after defecation. Reference 
intestinal samples were taken at autopsy from a 
full term child who died at 2 weeks of age from a 
mechanical respiratory insufficiency. Epithelial 
cells and stromal residue of small intestine were 
obtained through a stepwise washing procedure 
[13]. Corresponding epithelial and stromal frac- 
tions from the large intestine were obtained by 
scraping the mucosa after a careful rinsing of the 
colon. Glycosphingolipids were isolated from 
lyophilized samples and wet cells as described 
[13,14]. 
The preparations and antigenic specificities of 
the mouse monoclonal antibodies CO 19-9 and CO 
5 14 have been described [15,161 as has the overlay 
technique for immunostaining of glycosphingo- 
lipids [ 17,181. Thin-layer chromatography was per- 
formed on HPTLC plates (Si60, Merck, Darm- 
stadt) using glass support for chemical detection 
(anisaldehyde [19] or resorcinol [20]) and aluminia 
support for immunostaining with solvents chloro- 
form/methanol/water, 60: 35 : 8 (v/v), for non 
acid glycolipids and chloroform/methanol/0.2% 
CaC12, 60 : 40 : 9 (v/v), and chloroform/methanol/ 
2.5 M NH3, 60:40:9 (v/v), for acid glycolipids. 
Blood group typing of M.L. was done on meco- 
nium glycosphingolipids [21]. 
3. RESULTS 
The dry weights of the six collected feces 
samples varied from maximum 10.0 g (1 month) to 
minimum 0.8 g (5 months) and the yields of total 
non-acid glycolipids obtained from the feces dur- 
ing the 2 year period varied between 6.8 and 
15.0 mg/g dry tissue. The child M.L. was typed as 
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a blood group B Lewis(a+b-) non-secretor in- 
dividual. The pattern of non-acid glycosphingo- 
lipids in the feces during her first breast-fed 
months was similar to that found in the meconium 
[21] of a blood group A Lewis(a+b-) non-secretor 
individual (fig.1, lanes A, 1 and 2). Thus, cere- 
broside and a pentaglycosylceramide (fig. 1) were 
the dominating neutral glycosphingolipids in these 
excretions. Qualitative differences between the 
meconium and feces samples were seen mainly in 
the region of di- to tetra-glycosylceramides. This 
general pattern of two major neutral glycolipid 
species was also seen in the epithelial cell fractions 
from the autopsy material (fig. 1, lanes ES and EL) 
suggesting the same non-secretor character of this 
individual. Minor differences between the glyco- 
lipid patterns of the small and large intestines 
(lanes ES and EL) were observed and also reflected 
in fecal fractions (lanes 1 and 2). For the small in- 
testine no qualitative chemical differences were 
found between glycosphingolipids from villus tip 
and crypt cells (not shown) but as for the large in- 
testine marked differences were found between 
epithelial cells and residual mesenchymal stroma 
(fig.1). At the time of weaning, when solid food 
was introduced, the more complex glycosphingo- 
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Fig.1. Thin-layer chromatogram of total non-acid 
glycolipids of the meconium of a blood group A Le(a+b-) 
non-secretor (lane A), of feces of the chi1d.M.L. at 1 
(lane l), 2 (lane 2), 3 (lane 3), 4 (lane 4), and 5 (lane 5) 
months and the child J.H. at 23 (lane 23) months of age, 
and of epithelial cells (lane ES) and residual stroma (lane 
SS) of small intestine and of large intestine (lanes EL and 
SL) from a perinatally diseased child. For the feces 
samples the amount spotted on each lane corresponds to 
4 mg of dry feces. Figures to the left indicate the number 
of monosaccharide residues in the glycolipid 
carbohydrate chains. 
Volume 214, number 1 FEBS LETTERS April 1987 
lipids were generally diminished (fig.1) and 
simultaneously three strong bands of lactosyl- 
ceramide appeared (fig.1). No increase in cere- 
brosides was observed. During the following 
months lactosylceramide remained a dominating 
glycolipid in the feces although quantitative 
changes of more slow moving glycolipids were 
seen. Also in the feces from J.H. (2 years old) lac- 
tosylceramide was a major glycolipid but the pat- 
tern of blood group active glycolipids was different 
here (fig. 1, lane 23) and similar to that of the 
meconium of a blood group B Lewis(a-b+) secretor 
P4. 
The general patterns of gangliosides of the 
various feces and tissue samples are illustrated in 
fig.2. Hematoside, GM3, and a slower moving 
ganglioside were dominating in feces during the 
first months of life. From the time of weaning 
GM3 was gradually lost while the other major 
ganglioside was secreted unchanged for an addi- 
tional few months before its concentration in the 
feces also diminished. The fast-moving resorcinol- 
negative band seen in all the fecal fractions (fig.2) 
was identified using the meconium references, 
various solvent systems and the anisaldehyde 
reagent [23] as a mixture of cholesterol sulphate 
(CS) and sulphatide (S). Gangliosides were 
generally scarce in the small and large intestinal 
epithelial cells but enriched in the stromal frac- 
tions. These showed similar patterns for both acid 
and non-acid glycolipids along the intestinal tract. 
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Fig.2. Thin-layer chromatograrn of acid glycolipids of 
the feces and intestinal tissue samples of fig. 1. Lane AB 
corresponds to the acid meconium fraction of a blood 
group AB child and lane R contains GM3 and GM1 of 
human brain. The amount spotted on each lane of the 
feces samples corresponds to 4 mg of dry feces. The 
plate was sprayed with the resorcinol reagent [20]. The 
bands marked with an x did not show the characteristic 
blue colour of gangliosides. . 6). 
Fig.3. Autoradiograms of non-acid (panel A) and acid 
(panel B) glycolipids of feces of child M.L. at 1 (lanes l), 
2 (lanes 2), 3 (lanes 3), 4 (lanes 4) and 5 (lanes 5) months 
and J.H. at 23 (lanes 23) months of age after detection 
with Lea specific antibody (CO 514) and with ganglioside 
PWspecific antibody (CO 19-9). References used were 
meconium samples of a blood group A Le@+b-) non- 
secretor (lane A), a blood group B Lecamb+) secretor (lane 
B) and a blood group AB child (lane AB). Feces samples 
correspond to 2 mg dry tissue for non-acid glycolipids 
and 4 mg of dry tissue for acid glycolipids. 
Abbreviations at the sides indicate specifically stained 
glycolipids. The strong staining of a front band with CO 
19-9 was due to cholesterol sulphate (C’s) and sulphatide 
Using the blood group Lewis”-specific mono- 
clonal antibody (CO 514) [16] and the sensitive an- 
tibody overlay technique [16,17], the neutral 
pentaglycosylceramide of feces samples of child 
M.L. was shown to contain the Lewisa-deter- 
minant. This determinant was also detected on 
glycolipids with 7 and 9 or more monosaccharide 
residues per ceramide and the quantitative changes 
with time were in agreement with those found us- 
ing chemical detection. Lewisa-active pentaglyco- 
sylceramides were also detected in the meconium 
references of the blood group A Lewis(a+b-) non- 
secretor (lane A) and the blood group B 
Lewistamb+) secretor (lane B) as well as in feces of 
child J.H. at 2 years of age (lane 23). The fecal ex- 
cretion of the sialylated Lewisa glycolipid (the 
tumor-associated 19-9 antigen) is shown in fig.3B. 
In meconium a very high activity was seen but after 
birth there was a gradual loss of this ganglioside in 
the feces. At 2 years only minute amounts were ex- 
creted from the intestines of the Lewis positive 
secretor positive individual. 
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4. DISCUSSION 
We have shown for the first time that both acid 
and non-acid glycosphingolipids are excreted in the 
feces of humans from birth up to at least 2 years 
of age. The feces contains the final products of a 
very long series of events taking place within the 
gastrointestinal tract and the dynamics of fecal 
glycosphingolipids are now being studied. The 
problems of blood group individuality, stage- 
specific synthesis, luminal extrusion and bacterial 
degradation and contamination must be con- 
sidered. The illustrated induction of lactosyl- 
ceramide in the feces at the time of weaning was 
probably an effect of the microbial flora (un- 
published) and is interesting with respect to the 
possible role for this glycolipid as a receptor for 
luminal bacteria [f&11,12]. The excretion of non- 
degraded glycosphingolipids in feces might be of 
value for the early post-natal diagnosis of sphingo- 
lipidoses and if excretion persists in adulthood for 
the diagnosis of both inflammatory and neoplastic 
intestinal diseases. 
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